Zacks Research Estimates HCA Healthcare FY2026 Earnings

HCA Healthcare, Inc. (NYSE:HCA – Free Report) – Investment analysts at Zacks Research lifted their FY2026 earnings per share (EPS) estimates for shares of HCA Healthcare in a report released on Wednesday, November 11th. Zacks Research analyst Team now anticipates that the company will post earnings per share of $30.00 for the year, up from their previous estimate of $29.40. The consensus estimate for HCA Healthcare’s current full-year earnings is $30.14 per share. Zacks Research also issued estimates for HCA Healthcare’s Q4 2026 earnings at $8.04 EPS, Q1 2027 earnings at $7.36 EPS, Q2 2027 earnings at $7.63 EPS, Q3 2027 earnings at $7.35 EPS, Q4 2027 earnings at $8.53 EPS, FY2027 earnings at $30.87 EPS, Q1 2028 earnings at $8.06 EPS, Q2 2028 earnings at $8.16 EPS, Q3 2028 earnings at $8.66 EPS and FY2028 earnings at $33.98 EPS.

Several other analysts have also commented on HCA. Cantor Fitzgerald reaffirmed an “overweight” rating on shares of HCA Healthcare in a research report on Friday, October 2nd. Oppenheimer cut their target price on HCA Healthcare from $520.00 to $485.00 and set an “outperform” rating for the company in a research note on Monday, July 27th. Royal Bank Of Canada lifted their target price on HCA Healthcare from $496.00 to $521.00 and gave the company an “outperform” rating in a research report on Friday, October 30th. Weiss Ratings upgraded HCA Healthcare from a “buy (b-)” rating to a “buy (b)” rating in a report on Tuesday. Finally, TD Cowen raised their price objective on HCA Healthcare from $460.00 to $486.00 and gave the stock a “buy” rating in a research report on Wednesday, October 28th. Sixteen analysts have rated the stock with a Buy rating, seven have given a Hold rating and one has given a Sell rating to the company’s stock. According to data from MarketBeat.com, HCA Healthcare currently has an average rating of “Moderate Buy” and an average target price of $480.13.

View Our Latest Stock Analysis on HCA

HCA Healthcare Stock Down 0.4%

HCA traded down $1.84 during trading on Friday, reaching $498.82. The company’s stock had a trading volume of 971,100 shares, compared to its average volume of 1,447,928. The company has a market cap of $104.20 billion, a price-to-earnings ratio of 16.53, a PEG ratio of 1.67 and a beta of 1.11. The firm has a fifty day simple moving average of $452.79 and a two-hundred day simple moving average of $445.91. HCA Healthcare has a 1 year low of $353.99 and a 1 year high of $556.52.

HCA Healthcare (NYSE:HCA – Get Free Report) last announced its quarterly earnings results on Tuesday, October 27th. The company reported $7.22 earnings per share for the quarter, beating the consensus estimate of $6.65 by $0.57. The firm had revenue of $19.85 billion during the quarter, compared to analyst estimates of $19.33 billion. HCA Healthcare had a negative return on equity of 198.52% and a net margin of 8.61%. HCA Healthcare’s revenue for the quarter was up 3.6% compared to the same quarter last year. During the same quarter in the previous year, the business earned $6.96 EPS.

Institutional Trading of HCA Healthcare

Institutional investors and hedge funds have recently modified their holdings of the business. Cornermen Financial LLC purchased a new position in shares of HCA Healthcare during the 3rd quarter worth approximately $222,000. Empowered Funds LLC grew its holdings in HCA Healthcare by 5.7% during the 3rd quarter. Empowered Funds LLC now owns 25,560 shares of the company’s stock valued at $10,907,000 after buying an additional 1,384 shares during the last quarter. Roberts Glore & Co. Inc. IL increased its position in HCA Healthcare by 10.9% during the third quarter. Roberts Glore & Co. Inc. IL now owns 1,683 shares of the company’s stock worth $718,000 after buying an additional 166 shares in the last quarter. Healthcare of Ontario Pension Plan Trust Fund raised its holdings in shares of HCA Healthcare by 33.3% in the third quarter. Healthcare of Ontario Pension Plan Trust Fund now owns 226,189 shares of the company’s stock worth $96,524,000 after acquiring an additional 56,480 shares during the last quarter. Finally, Steward Partners Investment Advisory LLC lifted its position in shares of HCA Healthcare by 23.5% in the third quarter. Steward Partners Investment Advisory LLC now owns 3,208 shares of the company’s stock valued at $1,369,000 after acquiring an additional 611 shares in the last quarter. Hedge funds and other institutional investors own 62.73% of the company’s stock.

Insiders Place Their Bets

In other HCA Healthcare news, SVP Erica Rossitto sold 3,500 shares of the company’s stock in a transaction on Tuesday, November 10th. The stock was sold at an average price of $505.81, for a total value of $1,770,335.00. Following the sale, the senior vice president owned 13,426 shares of the company’s stock, valued at approximately $6,791,005.06. This represents a 20.68% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through the SEC website. Also, EVP Michael J. Schlosser sold 1,200 shares of HCA Healthcare stock in a transaction on Wednesday, November 4th. The stock was sold at an average price of $494.65, for a total value of $593,580.00. Following the transaction, the executive vice president directly owned 1,443 shares of the company’s stock, valued at $713,779.95. This trade represents a 45.40% decrease in their position. Additional details regarding this sale are available in the official SEC disclosure. Over the last quarter, insiders sold 36,413 shares of company stock worth $18,251,464. 1.50% of the stock is owned by corporate insiders.

HCA Healthcare Announces Dividend

The firm also recently disclosed a quarterly dividend, which will be paid on Tuesday, December 29th. Investors of record on Tuesday, December 15th will be issued a dividend of $0.78 per share. This represents a $3.12 dividend on an annualized basis and a yield of 0.6%. The ex-dividend date of this dividend is Tuesday, December 15th. HCA Healthcare’s dividend payout ratio is currently 10.34%.

Key Stories Impacting HCA Healthcare

Investors following HCA have been watching these stories:

  • Positive Sentiment: Value-focused articles describe HCA as a reasonably valued healthcare stock with long-term earnings-growth potential, supported by hospital demand and its scale. One analysis notes its valuation is below the sector median. Why HCA Healthcare is a Top Value Stock for the Long-Term
  • Neutral Sentiment: Zacks Research’s estimate changes were mixed: its FY2026 EPS forecast rose to $30.00, but it cut FY2027 to $30.87 and FY2028 to $33.98. The revisions offer a less uniformly strong forward earnings signal. HCA Healthcare analyst estimate updates
  • Negative Sentiment: Medicaid policy is a risk to earnings: HCA expects $550 million to $650 million less in Medicaid supplemental payment benefits in 2027, potentially adding reimbursement pressure. Value stocks offer a different path forward

HCA Healthcare Company Profile

(Get Free Report)

HCA Healthcare is a healthcare services company that operates hospitals and other care facilities. Its services include inpatient and outpatient care, emergency treatment, surgery, diagnostic services and specialized care across areas such as cancer and cardiovascular medicine. The company serves patients in the United States and the United Kingdom through its network of hospitals and outpatient facilities, including surgery centers, urgent care clinics and physician practices. Founded in 1968, HCA Healthcare is headquartered in Nashville, Tennessee.

See Also

Earnings History and Estimates for HCA Healthcare (NYSE:HCA)

Receive News & Ratings for HCA Healthcare Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for HCA Healthcare and related companies with MarketBeat.com's FREE daily email newsletter.